`
`
`
`MCF/mc
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`General Contact Number: 571-272-8500
`General Email: TTABInfo@uspto.gov
`
`January 17, 2019
`
`Opposition No. 91243291
`
`Lundbeck LLC
`
`v.
`
`
`
`By the Trademark Trial and Appeal Board:
`
`Novartis AG
`
`On December 10, 2018, Applicant filed a proposed amendment to its application
`
`Serial No. 79222202, with Opposer's consent, and Opposer's withdrawal of the
`
`opposition with prejudice, contingent upon entry of the amendment.
`
`By the proposed amendment, Applicant seeks to amend the identification of ^ from
`
`Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics;
`antifungal
`preparations;
`antivirals;
`cardiovascular
`pharmaceuticals;
`dermatological
`pharmaceutical
`preparations;
`inhaled
`pharmaceutical
`preparations for the prevention and treatment of respiratory diseases and
`disorders; pharmaceutical preparations acting on the central nervous system;
`pharmaceutical preparations and substances for the prevention and treatment of
`gastrointestinal diseases; pharmaceutical preparations for the prevention and
`treatment of diseases and disorders of the autoimmune system, the metabolic
`system, the endocrine system, the musculoskeletal system and the genitourinary
`system; pharmaceutical preparations for use in hematology and in tissue and
`organ transplantation; pharmaceutical preparations for the prevention and
`treatment of eye diseases and conditions; pharmaceutical preparations for the
`prevention and
`treatment of heart rhythm disorders; pharmaceutical
`preparations for the prevention and treatment of immune system related diseases
`and disorders; pharmaceutical preparations for the prevention and treatment of
`kidney diseases; pharmaceutical preparations for the prevention and treatment of
`
`
`
`
`
`Opposition No. 91243291
`
`
`diabetes; pharmaceutical preparations for the prevention and treatment of
`hypertension; pharmaceutical preparations for the prevention and treatment of
`skin disorders; pharmaceutical preparations
`for use
`in dermatology;
`pharmaceutical preparations for use in urology; pharmaceutical preparations for
`ophthalmological use; pharmaceutical preparations for the prevention and
`treatment of cancer and tumors; pharmaceutical preparations for the prevention
`and the treatment of allergies; pharmaceutical preparations for the prevention
`and treatment of bone diseases; pharmaceutical preparations for the prevention
`and treatment of respiratory diseases and asthma
`
`
`To:
`
`
`pharmaceutical preparations for the prevention and treatment of cancer and
`tumors.
`
`
`The amendment is limiting in nature, as required by Trademark Rule 2.71(a).
`
`Because Opposer consents thereto, the amendment is approved and entered. See
`
`Trademark Rule 2.133(a).
`
`The contingency in Opposer's withdrawal having now been met, the opposition is
`
`dismissed with prejudice.
`
`
`
`2
`
`